HIGHLIGHTS OF THE YEAR

Financial highlights

+11.3% adjusted operating profit

2023 : £655.7m
2022 : £589.2m
2021 : £530.2m

+6.1% adjusted EPS

2023 : 456.27p
2022 : 430.11p
2021 : 386.62p

+6.5 dividend per share

2023 : 187.21p
2022 : 175.78p
2021 : 159.80p

return on capital employed

2023 : 15.1%
2022 : 16.5%
2021 : 17.1%

SUSTAINABILITY HIGHLIGHTS

carbon intensity gCO₂e/MJ (scope 3)

2023 : 72.1gCO₂e/MJ
2022 : 76.4gCO₂e/MJ
2021 : 76.5gCO₂e/MJ

carbon emissions
(scope 1 and scope 2)

2023 : 96kts
2022 : 104kts
2021 : 96kts

gender diversity in 2023

2023: 63% male/37% female
2022: 63% male/37% female
2021: 65% male/35% female

maintenance of health and safety LTIFR

2023 : 0.97
2022 : 0.96
2021 : 1.04

AT A GLANCE

We provide solutions the world needs across three transformative sectors: energy, healthcare and technology; where we acquire, improve and grow diverse businesses. We bring our growth mindset to our businesses in 22 countries across four continents, empowering our 16,000+ employees to create long term value – for all our stakeholders.

16,100

employees

22

countries

4

continents

160 %

total returns generated over past decade

Compared to 74% for the FTSE 100 index

OUR SECTORS

We support solutions for progress and growth across three transformative sectors.

ENERGY

THE WORLD NEEDS CLEANER ENERGY FOR EVERYONE

PERFORMANCE

15.5 bn

-2.1%

volume (litres)

2023 : 15.5bn
2022 : 15.9bn
2021 : 13.9bn

£457.8 m

+12.4%

adjusted operating profit

2023 : £457.8m
2022 : £407.1m
2021 : £376.1m

2.95 ppl

adjusted operating profit per litre

2023 : 2.95ppl
2022 : 2.57ppl
2021 : 2.71ppl

19.0 %

return on capital employed

2023 : 19.0%
2022 : 18.6%
2021 : 18.1%

£573.9 m

operating cash flow

2023 : £573.9m
2022 : £518.4m
2021 : £674.9m

15.7 %

10-year adj. operating profit CAGR

2023 : 15.7%
2022 : 18.8%
2021 : 12.4%

STRATEGY IN ACTION: CREATING LEADERSHIP POSITIONS IN BIOFUELS

HEALTHCARE

THE WORLD NEEDS LIFELONG HEALTH

Performance

£821.5 m

+7.4%

revenue

2023 : £821.5m
2022 : £765.2m
2021 : £655.4m

£91.8 m

-8.6%

adjusted operating profit

2023 : £91.8m
2022 : £100.4m
2021 : £81.7m

11.2 %

operating margin

2023 : 11.2%
2022 : 13.1%
2021 : 12.5%

13.0 %

return on capital employed

2023 : 13.0%
2022 : 20.5%
2021 : 18.7%

£102.4 m

operating cash flow

2023 : £102.4m
2022 : £106.8m
2021 : £110.2m

15.9 %

10-year adjusted operating profit CAGR

2023 : 15.9%
2022 : 18.5%
2021 : 16.7%

STRATEGY IN ACTION: WIDER RANGE OF MEDICAL PRODUCTS FOR LONGER, HEALTHIER LIVES

TECHNOLOGY

THE WORLD NEEDS PROGRESS MAKERS

DCC TECHNOLOGY’S THREE PLATFORMS

Performance

£5.3 bn

+13.3%

revenue

2023 : £5.3bn
2022 : £4.6bn
2021 : £4.5bn

£106.1 m

+29.9%

adjusted operating profit

2023 : £106.1m
2022 : £81.7m
2021 : £72.4m

2.0 %

operating margin

2023 : 2.0%
2022 : 1.8%
2021 : 1.6%

8.7 %

return on capital employed

2023 : 8.7%
2022 : 9.1%
2021 : 12.3%

£184.4 m

operating cash flow

2023 : £184.4m
2022 : £3.2m
2021 : £118.6m

9.8 %

10-year adjusted operating profit CAGR

2023 : 9.8%
2022 : 7.0%
2021 : 7.2%

STRATEGY IN ACTION: EXERTIS JAM SUPPORTING CHAUVET

CHAIRMAN’S STATEMENT

The Group delivered another strong set of financial results, with adjusted operating profit growing to £655.7 million, an increase of 11.3% over the prior year. Return on capital employed remained over 15%.

This performance allowed us to extend the Group’s unbroken track record of increasing its dividend to shareholders to 29 years.

DCC’s clear strategy and business model are the foundation of the Group’s performance. We invest to generate returns. This means financial returns for our investors, and wider returns in the form of reduced carbon emissions, safe operations and attractive careers for diverse groups of people.

We also reinvest a proportion of the returns generated by Group business in organic growth and in acquisitions; and we return approximately 40% of adjusted earnings to shareholders each year.

The M&A capability of the Group, honed over 400 acquisitions, remains a key strength. We use this expertise to divest components of the Group when they no longer fit with strategy. This approach means we have clear capital allocation priorities, but remain agile in our approach, helping us fulfil our purpose of enabling people and businesses to grow and progress.

Mark Breuer, Chairman

Mark Breuer

Chairman

CHIEF EXECUTIVE’S REVIEW

The decisions we make today will have long-term social, environmental and financial effects.

We want those effects to be positive: returns for our investors, cleaner energy for everyone, lifelong health and progressive technology.

We invest and reinvest in businesses that deliver sustainable positive outcomes for all our stakeholders. As we grow, we generate more and more opportunities for further investment, development and growth.

This enables progress for all of our stakeholders, in line with our purpose.

Donal Murphy, Chief Executive

Donal Murphy

Chief Executive

KEY DOWNLOADS

Latest reports

ANNUAL REPORT 2023

Discover how we performed as a business in 2023.

SUSTAINABILITY REPORT 2023

Read about the sustainable progress we achieved in 2023.

Notice of AGM

See the letter from the Chairman and notice of the annual general meeting.

ESEF

Download our Annual Report ESEF filing.

CONTACTS

Get in touch with our team for any questions or enquiries.

Rossa White, Head of Investor Relations

Rossa White

Head of Investor Relations

Hollie Daly, Investor Relations Manager

Hollie Daly

Investor Relations Manager